Free Trial

Artiva Biotherapeutics (ARTV) Earnings Date, Estimates & Call Transcripts

Artiva Biotherapeutics logo
$2.64 -0.23 (-8.01%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$2.70 +0.06 (+2.46%)
As of 06:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artiva Biotherapeutics Earnings Summary

Artiva Biotherapeutics issued Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.87, which missed analysts' consensus estimates of -$0.84 by $0.03. With a trailing EPS of $0.00, Artiva Biotherapeutics' earnings are expected to grow next year, from ($4.95) to ($2.83) per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
-$0.84
Actual EPS
(Aug. 6)
-$0.87 Missed By -$0.03

Q2 2025 Earnings Resources

Get Artiva Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artiva Biotherapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ARTV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Artiva Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.68-$0.62-$0.65
Q2 20252-$0.71-$0.66-$0.69
Q3 20252-$0.74-$0.70-$0.72
Q4 20252-$0.76-$0.57-$0.67
FY 2025 8 -$2.89 -$2.55 -$2.72
Q1 20261-$0.73-$0.73-$0.73
Q2 20261-$0.76-$0.76-$0.76
Q3 20261-$0.78-$0.78-$0.78
Q4 20261-$0.81-$0.81-$0.81

Artiva Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025-$0.84-$0.87 -$0.03-$0.87--
5/8/2025--$0.68-$0.83 -$0.15-$0.83--
11/12/2024--$0.68-$0.92 -$0.24-$0.92$0.30M-
8/29/2024Q2 2024-$1.07-$19.10 -$18.03-$16.20--

Artiva Biotherapeutics Earnings - Frequently Asked Questions

Artiva Biotherapeutics (NASDAQ:ARTV) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on ARTV's earnings history.

In the previous quarter, Artiva Biotherapeutics (NASDAQ:ARTV) missed the analysts' consensus estimate of ($0.84) by $0.03 with a reported earnings per share (EPS) of ($0.87). Learn more on analysts' earnings estimate vs. ARTV's actual earnings.

Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded annual revenue of $250,000.00.

Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded net income of -$65.37 million. ARTV has generated $0.00 earnings per share over the last four quarters.

Artiva Biotherapeutics' earnings are expected to grow from ($4.95) per share to ($2.83) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ARTV) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners